Literature DB >> 3018586

Activation of two signal-transduction systems in hepatocytes by glucagon.

M J Wakelam, G J Murphy, V J Hruby, M D Houslay.   

Abstract

The ability of glucagon to stimulate glycogen breakdown in liver played a key part in the classic identification of cyclic AMP and hormonally stimulated adenylate cyclase. But several observations indicate that glucagon can exert effects independent of elevating intracellular cAMP concentrations. These effects are probably mediated by an elevation of the intracellular concentration of free Ca2+ although the mechanism by which this occurs is unknown. We show here that glucagon, at the low concentrations found physiologically, causes both a breakdown of inositol phospholipids and the production of inositol phosphates. Indeed, we show that the glucagon analogue, (1-N-alpha-trinitrophenylhistidine,12-homoarginine)glucagon (TH-glucagon), which does not activate adenylate cyclase or cause any increase in cAMP in hepatocytes yet can fully stimulate glycogenolysis, gluconeogenesis and urea synthesis, stimulates the production of inositol phosphates. This stimulation of inositol phospholipid metabolism by low concentrations of glucagon provides a mechanism whereby glucagon can exert cAMP-independent actions on target cells. We suggest that hepatocytes possess two distinct receptors for glucagon, a GR-1 receptor coupled to stimulate inositol phospholipid breakdown and a GR-2 receptor coupled to stimulate adenylate cyclase activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018586     DOI: 10.1038/323068a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

2.  Thyroid-stimulating hormone stimulates increases in inositol phosphates as well as cyclic AMP in the FRTL-5 rat thyroid cell line.

Authors:  J B Field; P A Ealey; N J Marshall; S Cockcroft
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

3.  Variations in the antagonistic effects of insulin and glucagon on glycogen metabolism in cultured foetal hepatocytes.

Authors:  P Menuelle; C Plas
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

4.  The glucagon receptor is required for the adaptive metabolic response to fasting.

Authors:  Christine Longuet; Elaine M Sinclair; Adriano Maida; Laurie L Baggio; Marlena Maziarz; Maureen J Charron; Daniel J Drucker
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

Review 5.  Calcium signaling in the liver.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

6.  The insulin receptor translocates to the nucleus to regulate cell proliferation in liver.

Authors:  Maria J Amaya; André G Oliveira; Erika S Guimarães; Marisa C F Casteluber; Sandhra M Carvalho; Lidia M Andrade; Mauro C X Pinto; Albert Mennone; Cleida A Oliveira; Rodrigo R Resende; Gustavo B Menezes; Michael H Nathanson; M Fatima Leite
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

7.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.

Authors:  M B Goldring; J Birkhead; L J Sandell; T Kimura; S M Krane
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Glucagon activates Ca2+ and Cl- channels in rat hepatocytes.

Authors:  Edoardo C Aromataris; Michael L Roberts; Greg J Barritt; Grigori Y Rychkov
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

Review 9.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

10.  Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis.

Authors:  Eva Tomas; Joel F Habener
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.